Jane Street Group, LLC Novavax Inc Put Options Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$10.71 - $17.11 $29 Million - $46.3 Million	2,705,700 New	2,705,700 $34.2 Million
Q1 2022 May 17, 2022	SELL	$69.73 - $142.9 $17.7 Million - $36.3 Million	-254,200 Reduced 22.11%	895,400 $65.9 Million
Q4 2021 Feb 15, 2022	BUY	$134.56 - $217.97 $56.7 Million - $91.9 Million	421,500 Added 57.89%	1,149,600 $164 Million
Q3 2021 Nov 16, 2021	BUY	$177.8 - $270.58 $10.6 Million - $16.2 Million	59,800 Added 8.95%	728,100 $151 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $37.3 Million - $79.5 Million	308,400 Added 85.69%	668,300 $142 Million
Q1 2021 May 18, 2021	SELL	$112.98 - $319.93 $7.77 Million - $22 Million	-68,800 Reduced 16.05%	359,900 $65.3 Million
Q4 2020 Feb 17, 2021	BUY	$78.74 - $139.5 $1.05 Million - $1.86 Million	13,300 Added 3.2%	428,700 $47.8 Million
Q3 2020 Nov 17, 2020	SELL	$79.44 - $178.51 $12.7 Million - $28.6 Million	-160,400 Reduced 27.86%	415,400 $45 Million
Q2 2020 Aug 17, 2020	BUY	$13.86 - $83.61 $7.08 Million - $42.7 Million	510,900 Added 787.21%	575,800 $48 Million
Q1 2020 May 15, 2020	BUY	$3.93 - $16.0 $255,057 - $1.04 Million	64,900 New	64,900 $881,000

289

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $657M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.